R
Retina Vitreous Consultants | Monroeville, PA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
APL-2
Lampalizumab
DE-109
Pemafibrate
Pegcetacoplan
Bevacizumab
bevacizumab
Sirolimus
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 12 total trials
This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...
Active, not recruiting
Geographic Atrophy Secondary to Age-related Macular Degeneration
Drug: PEGCETACOPLAN (APL-2)
Trial sponsors
A
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems